Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
HYDROCHLOROTHIAZIDE, DEXAMETHASONE
Vetoquinol Ireland Limited
QC03AX01
HYDROCHLOROTHIAZIDE, DEXAMETHASONE
Unknown
Solution for Injection
POM
Bovine, Equine Non Food
Hydrochlorothiazide, combinations
Cardiovascular
Authorised
1989-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Diurizone Injectable 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. A colourless, slightly viscous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle Horses declared as not being intended for slaughter for human consumption. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _Cattle:_ Congestion and oedema of the udder Persistent oedema during lactation Pulmonary congestion and oedema Oedema of surgical wounds Oedema of allergic conditions _Horses:_ Generalised congestion and oedema Oedema of sheath Anasarca Oedema in allergic conditions 4.3 CONTRAINDICATIONS Do not use in pregnant animals. Do not use in animals with viral infections, during the viraemic phase. Do not use in animals with diabetes mellitus, congestive heart failure, chronic nephritis, osteoporosis or glaucoma. Do not use in animals with hepatic encephalopathy. Do not use in cases of severe hypokalemia. Do not use in animals with known hypersensitivity to the active ingredients. Do not use in horses for the treatment of laminitis. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Each ml contains: ACTIVE SUBSTANCES Hydrochlorothiazide 50 mg Dexamethasone 0.5 mg EXCIPIENT Benzyl Alcohol 0.01 ml HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 16/09/2015_ _CRN 7021887_ _page number: 1_ None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS For intravenous administration, use a tepid solution and inject slowly. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS None. 4.6 ADVERSE REACTIONS (FREQUEN Read the complete document